Diagnosis and Management of Diabetic Neuropathies Aaron I. Vinik, MD, PhD, FCP, MACP Professor of Medicine/Pathology/Neurobiology Director of Research.

Slides:



Advertisements
Similar presentations
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Advertisements

Upper vs. Lower Body Aerobic Training in Patients with Claudication Diane Treat-Jacobson, PhD, RN Assistant Professor of Nursing Center for Gerontological.
Change in Abdominal Obesity & Risk of Coronary Calcification Siamak Sabour, MD, MSc, DSc, PhD, Postdoc Clinical Epidemiologist Persian International Epidemiology.
Pathophsiology of Metabolism. Obesity What Is Obesity? Obesity means having too much body fat.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
BURDEN OF ILLNESS. Overview Patient-Reported Burden of Neuropathic Pain Is Significant 3 Cruz-Almeida Y et al. J Rehab Res Dev 2005; 42(5):585-94; Gilron.
EPIDEMIOLOGY. General 5–20% of the General Population May Suffer from Neuropathic Pain Summary of Selected Prevalence Studies Adapted from: Bouhassira.
T2DM MANAGEMENT DENTAL COURSE Mohamed AlMaatouq, MD King Khalid University Hospital King Saud University.
1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Edward J. Bastyr III, MD Promoting Clear Identification of Diabetic Peripheral.
Slides current until 2008 Diabetic neuropathy. Curriculum Module III-7C Slide 2 of 37 Slides current until 2008 Diabetic foot disease – the high-risk.
Chronic Inflammatory Demyelinating Polyneuropathy By: Kyle Leato, SPTA.
Diabetic painful neuropathy Dr. Ashok Kumar Das. Diabetic painful neuropathy This is a definite subset of diabetic neuropathy and requires more attention.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Glucose Levels and Risk of Dementia Presented by - Anas Kabaha, MD Sheba medical center Sheba medical center August 8,2013.
1 Prediabetes Burden. 2 Epidemiology: Health Performance Gaps Prevalence Risk factors –Metabolic syndrome –Obesity Clinical risks of prediabetes –Progression.
Minimally Invasive Surgery Symposium Modest Weight Loss in T2 DM: Lessons from the Look AHEAD Trial Donna H. Ryan, MD Pennington Biomedical Research Center.
Identifying the Presence of Peripheral Artery Disease in Patients With and Without Diabetes Lori Brown, PharmD and Charles Herring, PharmD, BCPS, CPP University.
Does the weight history of patients with newly diagnosed type 2 diabetes influence the weight changes after diabetes diagnosis? Niels de Fine Olivarius.
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
SPINAL NERVE ROOT COMPRESSION AND PERIPHERAL NERVE DISORDERS Group A – AHD Dr. Gary Greenberg.
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
Chronic pain Sai Yan Au. Chronic Pain  Definition  Causes and mechanisms of chronic pain  Effects of chronic pain  Assessment and evaluation  Management.
Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
Diagnosis and Management of Diabetic Neuropathies Aaron I. Vinik, MD, PhD, FCP, MACP Professor of Medicine/Pathology/Neurobiology Director of Research.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
FDA Endocrinologic and Metabolic Drugs Advisory Committee 1st June 2008 Rury Holman Clinical outcomes with anti-diabetic drugs: What we already know.
Risk of Type 2 Diabetes and It’s Complications Along The Continuum of Fasting Plasma Glucose Gregory A. Nichols, PhD Collaborative Diabetes Education Conference.
Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.
Diagnosis and Management of Diabetic Neuropathies Part 3 Aaron I. Vinik, MD, PhD, FCP, MACP Professor of Medicine/Pathology/Neurobiology Director of Research.
Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP
Farid Saad Euro Weight Loss-2015 Frankfurt, Germany August 18 – 20, 2015.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015 Stan Schwartz MD,FACP Affiliate, Main Line Health System Emeritus, Clinical Associate Professor.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
Diagnosis and Management of Diabetic Neuropathies Part 4
Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.
Individualization Strategies for Older Patients with Diabetes Elbert S. Huang, MD MPH FACP University of Chicago.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Mrs. Watcharasa Pitug ID The Association between Waist-to-Hight ratio, waist circumference,and Body Mass Index as Risk Factors for Chronic.
Prevention of complications of endocrine disorders R.Fielding Department of Community Medicine, HKU.
Diabetes Prevention Program (DPP)
Presented by Mark Rowbotham, M.D. at the Anesthetic and Life Support Drugs Advisory Committee Meeting on May 16, 2002.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Peripheral Neuropathy Clinical Management Course February 12, 2007
Date of download: 5/29/2016 From: Statins and Cognitive Function: A Systematic Review Ann Intern Med. 2013;159(10): doi: /
DIABETIC NEUROPATHY PAWUT MEKAWICHAI MD DEPARTMENT OF MEDICINE MAHARAT NAKORNRAJSIMA HOSPITAL.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Pudendal Nerve Entrapment
6-year vision loss in patients newly diagnosed with clinical type 2 diabetes. What can the patients expect? Niels de Fine Olivarius Volkert Siersma Gitte.
Steps to Avoid Injury in Exercise Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Weight.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Diagnosis and Management of Diabetic Neuropathies Part 5 Aaron I. Vinik, MD, PhD, FCP, MACP Professor of Medicine/Pathology/Neurobiology Director of Research.
ALICE-PROTECT Study Yields Online Risk Prediction Tool in Diabetic Nephropathy From ESH 2016 | LB 1: Jean-Pierre Fauvel, MD CHU Lyon, Hôpital E Herriot,
Copyright © 2011 American Medical Association. All rights reserved.
Mrs. Watcharasa Pitug ID
Copyright © 2007 American Medical Association. All rights reserved.
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,
Screening and Monitoring
Strategies for the Practical Management of Type 2 Diabetes
Younger women with symptomatic peripheral arterial disease are at increased risk of depressive symptoms  Kim G. Smolderen, PhD, John A. Spertus, MD, MPH,
VALUE: New-onset diabetes in an amlodipine-based vs valsartan-based therapy in high-risk hypertensives Diagnostic criteria Valsartan n (%) Amlodipine n.
Baseline Characteristics of the Subjects*
RECORD Study: Enrollment and Outcomes
PEREHHRAL NERVOUS SYSTEM
Presentation transcript:

Diagnosis and Management of Diabetic Neuropathies Aaron I. Vinik, MD, PhD, FCP, MACP Professor of Medicine/Pathology/Neurobiology Director of Research and Neuroendocrine Unit Eastern Virginia Medical School Strelitz Diabetes Center for Endocrine and Metabolic Disorders Norfolk, Virginia Part 1

An early description of neuropathy in Hittite tablets ‘If King Hattusili III is cured from the fire that burns his feet, I will give a golden cup with a handle of lapis lazuli to Goddess Ningal’ Queen Puduhepa, approx 1250 BC The king could not attend the wedding of his daughter Maathorneferure because of his burning feet Öztürk, 2006

EURODIAB: Risk Factors for Incidence of Polyneuropathy Tesfaye S, et al. N Engl J Med. 2005;352: Model 1: excluding cardiovascular disease and retinopathy Odds ratios (95% CI); n = 1101 with type 1 diabetes; follow-up 7.3 ± 0.6 years Smoking 1.38 Hemoglobin A 1c Change in hemoglobin A 1c Body mass index Total cholesterol Triglycerides Hypertension 1.57 Diabetes duration 1.40

Multivariate models All subjects (n = 393) Age (years) Weight (kg) Diabetes Peripheral arterial disease (ABI < 0.9) Subjects With Diabetes (n = 195) Age (years) Weight (kg) Peripheral arterial disease (ABI < 0.9) Albuminuria (mg/L) OR (95% CI) 1.08 (1.02, 1.14) 1.03 (1.00, 1.05) 2.61 (1.09, 6.24) 5.72 (2.44, 13.39) OR (95% CI) 1.08 (1.00, 1.16) 1.03 (1.00, 1.06) 9.27 (3.44, 25.0) 1.19 (0.95, 1.51) P value <.0001 P value < Ziegler D, et al. Eur J Pain. 2008, doi: /j.ejpain ABI = ankle brachial index; OR = odds ratio; CI = confidence interval Risk Factors for Neuropathic Pain MONICA/KORA Augsburg Surveys S2+S3

Prevalence of Polyneuropathy and Neuropathic Pain MONICA/KORA Augsburg Surveys S2S3 Ziegler D et al. Diabetes Care. 2008;31:464. Ziegler D et al. Eur J Pain. 2009; in press Control Impaired fasting glucose Impaired glucose tolerance Diabetes Polyneuropathy Neuropathic pain Patients (%)

Prevalence of Chronic Neuropathic Pain in French General Population Nationwide postal questionnaire survey –30,155 subjects, 81.2% responded 1631 respondents had chronic pain with neuropathic characteristics: 6.9% prevalence Bouhassira D et al. Pain. 2008;136: DN4 Score Patients (%)

Review of computerized longitudinal medical records –362,693 persons; 1,116,215 person-years (PY) Incidence (new cases): 8.2/1000 PY; diabetic neuropathy: 0.72/1000 PY; postherpetic neuralgia: 0.42/1000 PY Most treated with NSAIDs and aspirin; <5% treated with anticonvulsants and tricyclic antidepressants Incidence and Treatment of Neuropathic Pain in Dutch Population Dieleman JP et al. Pain. 2008; 137: > Incidence rate/1000 PY Ratio female:male Age (years) Incidence rate/1000 PY Age (years) > DPN PHN Mononeuropathy Incidence rate ratio of women vs men MenWomen

Neuropathy in Diabetes Prevalence % Things that he stretched but mainly he tells the truth Mark Twain

Neuropathy Is Commonly Underdiagnosed Endocrinologists Non-endocrinologists Herman W et al. Presented at: 63rd Annual Scientific Sessions of the American Diabetes Association. New Orleans, LA; June 13-17, Abstract 830-P. Herman et al. Diabetes Care. 2005;28:1480. Correct diagnosis (%) For every mistake made for not knowing, 10 are made for not looking No neuropathy (n=4628) Non-severe neuropathy (n=2209) Severe neuropathy (n=541)

Diabetic Neuropathies Large-fiber neuropathy Small-fiber neuropathy Proximal motor neuropathy Acute mono neuropathies Entrapment Sensory loss: 0 – + (thermal allodynia) Pain: + – +++ Tendon reflex: N –  Motor deficit: 0 Sensory loss: 0 – +++ (touch vibration) Pain: + – +++ Tendon reflex: N –  Motor deficit: 0 – +++ Sensory loss: 0 – + Pain: + – +++ Tendon reflex:  Proximal motor deficit: + – +++ Sensory loss: 0 – + Pain: + – +++ Tendon reflex: N Motor deficit: + – +++ Sensory loss in nerve distribution: + – +++ Pain: + – ++ Tendon reflex: N Motor deficit: + – +++ N, normalVinik A et al. Clin Geriatr Med. 2008;24:407. IIIVI Truncal Ulnar Median Lateral popliteal

Mononeuritis vs Entrapment Mononeuritis Onset sudden Usually single nerve, but may be multiple Common nerves: C3, C6, C7, ulnar, median, peroneal Not progressive and resolves spontaneously Treatment: symptomatic Entrapment Onset gradual Single nerves exposed to trauma Common nerves: median, ulnar, peroneal, medial and lateral plantar Progressive Treatment: rest, splints, diuretics, steroid injections and surgery for failed medical therapy and weakness Vinik A et al. Diabetes Care. 2004;27:1783.C, cranial nerve

A Simplified View of the PNS MotorSensoryAutonomic Myelinated Thinly myelinated Un- myelinated Thinly myelinated Un- myelinated A alpha A alpha/beta A delta C A delta C Large Muscle control Touch, vibration, position perception Cold perception, pain Warm perception, pain Heart rate, blood pressure, sweating, GIT,GUT, function Small Vinik AI, et al. Nature Clinical Practice Endocrinol Metab. 2006;2: